Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039022

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 2039022

Companion Animal Drugs Market, By Product Type, By Distribution Channel, By Geography

PUBLISHED:
PAGES: 152 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4500
PDF & Excel (Multi User License - Up to 7 Users)
USD 7000
PDF & Excel (Corporate User License)
USD 10000

Add to Cart

Companion Animal Drugs Market is estimated to be valued at USD 28.8 Bn in 2026 and is expected to reach USD 44.9 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 28.8 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 6.80% 2033 Value Projection: USD 44.9 Bn

Companion animal include dog, cat, fish, bird, horse, rabbit, hamster, guinea pig, and ferret. Companion animals are used for company, amusement, psychological support, extrovert display and all of the other functions that humans need to share with animals of other species. Increasing adoption of companion animals is expected to propel growth of the global companion animal drugs market over the forecast period. Furthermore, high prevalence of salmonella infection, along with increasing animal healthcare expenditure is also anticipated to assist the market growth during the forecast period.

Key features of the study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the Global Companion Animal Drugs market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Zoetis Inc., Merck & Co., Inc., Bayer AG, Eli Lily & Co., Sanofi (Merial), Ceva Sante Animal, Virbac Animal Health, and Boehringer Ingelheim GmbH
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Global Companion Animal Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Global Companion Animal Drugs market

Market Segmentation

  • By Product Type
    • Antibiotics
    • Anti-inflammatory
    • Parasiticides
    • Ecto-Parasiticides
    • Endo-Parasiticides
    • Heart worm Products
    • Behavioral Products
    • Nutritional Products
    • Skin care Products
    • Vaccines
  • By Distribution Channel
    • Veterinary Hospitals
    • Veterinary Clinics
    • Pharmacies and Drug Stores
  • By Region
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East & Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa
  • Key Players
    • Zoetis Inc.
    • Merck & Co., Inc.
    • Bayer AG
    • Eli Lily & Co.
    • Sanofi (Merial)
    • Ceva Sante Animal
    • Virbac Animal Health
    • Boehringer Ingelheim GmbH
Product Code: CMI1203

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Product Approval
  • Collaboration/Merge/Acquisition
  • Regulatory Landscape
  • PEST Analysis
  • Porter's Five Forces Analysis
  • Epidemiology
  • Robust Pipeline Analysis

4. Global Companion Animal Drugs Market, By Product Type, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026- 2033
    • Segment Trends
  • Antibiotics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Anti-inflammatory
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Ecto-Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Endo-Parasiticides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Heart worm Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Behavioral Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Nutritional Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Skin care Products
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Vaccines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Global Companion Animal Drugs Market, By Distribution Channel, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2026 - 2033
    • Segment Trends
  • Veterinary Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Veterinary Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
  • Pharmacies and Drug Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Global Companion Animal Drugs Market, By Region, 2026 - 2033, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, For Regions, 2026-2033
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Heat Map Analysis
  • Market Share Analysis
  • Company Profile
    • Zoetis Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Bayer AG
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Eli Lily & Co.
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Sanofi (Merial)
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Ceva Sante Animal
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Virbac Animal Health
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
    • Boehringer Ingelheim GmbH
  • Company Highlights
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Market Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!